68 related articles for article (PubMed ID: 15869458)
1. Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings.
Limouris GS; Dimitropoulos N; Kontogeorgakos D; Papanikolos G; Koutoulidis V; Hatzioannou A; Mourikis D; Lyra M; Dimitriou P; Stravaka A; Vlahos L
Cancer Biother Radiopharm; 2005 Apr; 20(2):215-7. PubMed ID: 15869458
[TBL] [Abstract][Full Text] [Related]
2. [111-indium DTPA octreotide scintigraphy in colorectal liver metastases].
Seifert JK; Görges R; Bockisch A; Junginger T
Langenbecks Arch Chir; 1997; 382(6):332-6. PubMed ID: 9498205
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.
Gibril F; Reynolds JC; Doppman JL; Chen CC; Venzon DJ; Termanini B; Weber HC; Stewart CA; Jensen RT
Ann Intern Med; 1996 Jul; 125(1):26-34. PubMed ID: 8644985
[TBL] [Abstract][Full Text] [Related]
4. Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
Van Binnebeek S; Deroose CM; Baete K; Terwinghe C; Vanbilloen B; Koole M; Haustermans K; Mortelmans L; Verslype C; Van Cutsem E; Verbruggen A; Mottaghy FM
J Clin Oncol; 2011 Jul; 29(19):e579-81. PubMed ID: 21555687
[No Abstract] [Full Text] [Related]
5. In-111 octreotide scan in a case of a neuroendocrine tumor of unknown origin.
Fuster D; Navasa M; Pons F; Vidal-Sicart S; Mateos JJ; Lomeña F; Rodes J; Herranz R
Clin Nucl Med; 1999 Dec; 24(12):955-8. PubMed ID: 10595476
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing small hepatic hemangiomas from vascular liver metastases in gastrinoma: use of a somatostatin-receptor scintigraphic agent.
Termanini B; Gibril F; Doppman JL; Reynolds JC; Stewart CA; Sutliff VE; Venzon DJ; Jensen RT
Radiology; 1997 Jan; 202(1):151-8. PubMed ID: 8988205
[TBL] [Abstract][Full Text] [Related]
7. Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
De Jong M; Breeman WA; Bernard HF; Kooij PP; Slooter GD; Van Eijck CH; Kwekkeboom DJ; Valkema R; Mäcke HR; Krenning EP
Q J Nucl Med; 1999 Dec; 43(4):356-66. PubMed ID: 10731786
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine carcinomas of the lung and role of 111In-DTPA-octreotide scintigraphy: preliminary results.
Oliaro A; Filosso PL; Bello M; Casadio C; Muni A; Greco B; Bertuccio G; Bisi G; Maggi G
J Cardiovasc Surg (Torino); 1996 Dec; 37(6):653-6. PubMed ID: 9016988
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary results on the use of scintigraphy with radiolabelled octreotide as diagnostic method in neuroendocrine and nonendocrine neoplasms of the lung].
Oliaro A; Filosso PL; Bellò M; Casadio C; Muni A; Angusti T; Masaneo I; Bisi G; Maggi G
Minerva Chir; 1997 Nov; 52(11):1335-8. PubMed ID: 9489331
[TBL] [Abstract][Full Text] [Related]
10. Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome.
Fjälling M; Andersson P; Forssell-Aronsson E; Grétarsdóttir J; Johansson V; Tisell LE; Wängberg B; Nilsson O; Berg G; Michanek A; Lindstedt G; Ahlman H
J Nucl Med; 1996 Sep; 37(9):1519-21. PubMed ID: 8790206
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of (111)In-DTPA(0)-octreotide on intrahepatic tumor growth after partial hepatectomy.
Slooter GD; Aalbers AG; Breeman WA; Hiemstra CA; Marquet RL; Krenning EP; van Eijck CH
J Nucl Med; 2002 Dec; 43(12):1681-7. PubMed ID: 12468520
[TBL] [Abstract][Full Text] [Related]
12. [A case of metastatic gastrinomas in the liver visualized by 111In-DTPA-D-Phe-octreotide (111In-pentetreotide)].
Tani A; Nakabeppu Y; Tsuchimochi S; Nakajo M; Yoshinaga T; Kiku T
Kaku Igaku; 1996 May; 33(5):545-9. PubMed ID: 8699623
[TBL] [Abstract][Full Text] [Related]
13. Therapy using labelled somatostatin analogues: comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide.
Barone R; Walrand S; Konijnenberg M; Valkema R; Kvols LK; Krenning EP; Pauwels S; Jamar F
Nucl Med Commun; 2008 Mar; 29(3):283-90. PubMed ID: 18349800
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial treatment with 90yttrium microspheres in treatment-refractory and unresectable liver metastases of neuroendocrine tumors and the use of 111in-octreotide scintigraphy in the evaluation of treatment response.
Lacin S; Oz I; Ozkan E; Kucuk O; Bilgic S
Cancer Biother Radiopharm; 2011 Oct; 26(5):631-7. PubMed ID: 21950557
[TBL] [Abstract][Full Text] [Related]
15. Treatment with high dose [(111)In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors--evaluation of therapeutic and toxic effects.
Tiensuu Janson E; Eriksson B; Oberg K; Skogseid B; Ohrvall U; Nilsson S; Westlin JE
Acta Oncol; 1999; 38(3):373-7. PubMed ID: 10380830
[TBL] [Abstract][Full Text] [Related]
16. Metastasis of neuroendocrine colon carcinoma mimicking Graves' ophthalmopathy.
Busse F; Führer D; Stumvoll M; Schneider JP; Neid M; Kluge R; Sterker I
Thyroid; 2008 Nov; 18(11):1237-8. PubMed ID: 18925841
[No Abstract] [Full Text] [Related]
17. Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI.
Giesel FL; Kratochwil C; Mehndiratta A; Wulfert S; Moltz JH; Zechmann CM; Kauczor HU; Haberkorn U; Ley S
Eur J Radiol; 2012 Oct; 81(10):2820-5. PubMed ID: 22236704
[TBL] [Abstract][Full Text] [Related]
18. Selective hepatic arterial infusion of In-111-DTPA-Phe1-octreotide in neuroendocrine liver metastases.
Limouris GS; Chatziioannou A; Kontogeorgakos D; Mourikis D; Lyra M; Dimitriou P; Stavraka A; Gouliamos A; Vlahos L
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1827-37. PubMed ID: 18536916
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor gene therapy combined with targeted therapy with radiolabeled octreotide: a new treatment for liver metastases.
Mearadji A; Breeman W; Hofland L; van Koetsveld P; Marquet R; Jeekel J; Krenning E; van Eijck C
Ann Surg; 2002 Dec; 236(6):722-8; discussion 728-9. PubMed ID: 12454510
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with somatostatin receptor imaging in lymphoma.
Bong SB; VanderLaan JG; Louwes H; Schuurman JJ
Semin Oncol; 1994 Oct; 21(5 Suppl 13):46-50. PubMed ID: 7992081
[No Abstract] [Full Text] [Related]
[Next] [New Search]
